Clinical Trial

Healthy Volunteers Study

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to examine the role of the bacterial environments and metabolites in the early detection and prediction of ovarian cancer development. Vaginal swabs and stool samples will be collected from healthy volunteers, or those without a known ovarian cancer diagnosis or genetic ovarian cancer risk. These samples will be compared to samples from participants with increased cancer risk and ovarian cancer diagnoses.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-29.
Trial Details
NCT Number NCT06962059
Lead Sponsor Abramson Cancer Center at Penn Medicine
Conditions Ovarian Cancer, Genetic Predisposition to Disease
Enrollment 50 participants
Start Date 2025-04-21
Primary Completion 2027-01-15 (estimated)
Study Completion 2027-05-25 (estimated)
Updated on ClinicalTrials.gov 2026-02-05